+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16



Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16



Veterinary Microbiology 146(1-2): 44-50



In the 2004, the Sardinian bluetongue (BT) vaccination campaign used the combination of monovalent BTV-2, BTV-4 and BTV-16 modified-live vaccines manufactured by the Onderstepoort Biological Products in South Africa. Following vaccination, some herds showed temperature, oedema, lameness, hyperaemia and decrease in milk production, and some others remained perfectly healthy. This study aimed to evaluate whether important factors present in the herd at the time of vaccination could be associated to the occurrence of undesired effects observed after immunisation with BTV modified-live vaccines. A sample of 17 sheep and 4 goat flocks, for a total of 670 animals, were included in the study and risk factors such as presence of most important parasitic, bacterial and viral diseases as well as anomalies of biochemical and haematological parameters were associated to the presence or absence of side effects. For each factor the relative risk and 95% confidence interval were calculated. Following vaccination, bluetongue-like symptoms were observed in 13 flocks. In these flocks, a higher (P<0.05) proportion of animals had viraemia and showed higher titers to BTV-16 after immunisation. Positive association (RR=2.50, 1.17-5.04) was also found between flocks in which undesired effect were observed and positive serology against Maedi-Visna virus. On the contrary, presence of BTV genome fractions in the blood of animals at the time of vaccination was found to be protective (RR=0.7, 0.58-0.84) to the occurrence of undesired effect subsequent to BTV vaccination.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579914

Download citation: RISBibTeXText

PMID: 20537822

DOI: 10.1016/j.vetmic.2010.04.020


Related references

Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9. Veterinaria Italiana 40(4): 631-634, 2004

Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production. Veterinaria Italiana 40(4): 627-630, 2004

Field vaccination of cattle using a bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production. Veterinaria Italiana 40(4): 661-663, 2004

Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9. Veterinaria Italiana 40(4): 657-660, 2004

Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4. Vaccine 28(5): 1397-1403, 2010

Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17. Journal of the American Veterinary Medical Association 248(9): 1043-1049, 2016

Studies on bluetongue. IV. Field trial of a modified live virus vaccine. Journal of the American Veterinary Medical Association 128(9): 454-456, 1956

Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2. Veterinaria Italiana 40(4): 668-670, 2004

Effects of bluetongue live modified vaccine on early and mid pregnancy in sheep. 2008

Vaccination of cattle using monovalent modified-live vaccine against bluetongue virus serotype 2: innocuity, immunogenicity and effect on pregnancy. Veterinaria Italiana 40(4): 671-675, 2004

Experimental vaccination of sheep using a bluetongue attenuated live vaccine: a study of the effects on lactation. Veterinaria Italiana 39(48): 5-10, 2003

Tonsilar crypt exudate to evaluate shedding and transmission of porcine reproductive and respiratory syndrome virus after inoculation with live field virus or vaccination with modified live virus vaccine. Journal of Swine Health and Production 15(4): 219-223, 2007

Studies on bluetongue. III. The development of a modified live virus vaccine employing American strains of bluetongue virus. American Journal of Veterinary Research 18(67): 310-316, 1957

Studies on bluetongue. III. The development of a modified live vaccine employing American strains of bluetongue virus. Amer. J. vet. Res, 18: 310-316, 1957

Serodiagnostic evidence of prevalence of bluetongue virus serotypes among sheep and goats in Tamil Nadu. Indian Journal of Animal Sciences 61(5): 497-498, 1991